Brief: Tectonic Therapeutic To Present Phase 1B Data For Tx45 At European Society Of Cardiology Heart Failure 2025
15/04/2025 14:23
April 15 (Reuters) - Tectonic Therapeutic Inc TECX.O: TECTONIC THERAPEUTIC TO PRESENT PHASE 1B DATA FOR TX45 AT EUROPEAN SOCIETY OF CARDIOLOGY HEART FAILURE 2025 Source text: ID:nGNX44h8VP Further company coverage: TECX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tectonic Therapeutic
See all newsTectonic Therapeutic Inc reports results for the quarter ended June 30 - Earnings Summary
Tectonic Therapeutic Q2 net loss widens on higher costs
Tectonic Therapeutic Inc expected to post a loss of $1.35 a share - Earnings Preview
Brief: Tectonic Therapeutic Completes Enrollment In Tx45 Apex Phase 2 Clinical Trial In Ph-Hfpef Patients
Tectonic Therapeutic Q1 net loss widens on higher R&D costs